Extractable nuclear antigen effect on the DNA anti-DNA reaction and NZB/NZW mouse nephritis.

A D Morris; C Littleton; L C Corman; J Esterly; G C Sharp

doi:10.1172/JCI108018

Find articles by Morris, A. in: JCI | PubMed | Google Scholar

Find articles by Littleton, C. in: JCI | PubMed | Google Scholar

Find articles by Corman, L. in: JCI | PubMed | Google Scholar

Find articles by Esterly, J. in: JCI | PubMed | Google Scholar

Find articles by Sharp, G. in: JCI | PubMed | Google Scholar

Published in Volume 55, Issue 5 on May 1, 1975
J Clin Invest. 1975;55(5):903–907. https://doi.org/10.1172/JCI108018.
© 1975 The American Society for Clinical Investigation

Published May 1, 1975 - Version history

Extractable nuclear antigen (ENA) is composed of at least two components, one a ribonucleo-protein sensitive to ribonuclease or heat and the other a protein. Antibodies to ENA are associated with a relatively benign clinical course in patients with systemic lupus erythematosus (SLE) in which DNA anti DNA complexes are thought pathogenic. The effect of ENA and anti-ENA on DNA anti-DNA reactions in vitro was studied. ENA effectively inhibited an anti-DNA hemagglutination reaction but no effect was found on binding of radioactive DNA or on the anti-hemocyanin hemagglutination reaction. The inhibitory effect was not abolished by yeast ribonuclease (RNase), heating, or DNase. Anti-ENA HAD NO EFFECT ON ANTI-DNA hemagglutination. In vivo, ENA altered the NZB/NZW mouse nephritis thought to be a model for human SLE nephritis. These results suggest the possiblity of a role for ENA in alteration of diseases due to pathogenic DNA anti-DNA complexes.

Click on an image below to see the page. View PDF of the complete article